Mortality risk factors in patients with zygomycosis: A retrospective and multicentre study of 25

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue 4, 2011, Pages 263-268

  Llorente, Andreu ^a   Perez Valero, Ignacio ^b   Garcia E ^c   Heras, I ^d   Fraile, V ^e   Garcia P ^f   Lopez J ^g   Salavert, M ^h   Bobillo, F ⁱ  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Liposomal amphotericin B; Mortality; Risk factors; Zygomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CORTICOSTEROID; DEFEROXAMINE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ACIDOSIS; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTRANSPLANTATION; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BRAIN INFECTION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; COMMUNICABLE DISEASE; CORTICOSTEROID THERAPY; CYTOMEGALOVIRUS INFECTION; DEBRIDEMENT; DEMOGRAPHY; DERMATOMYCOSIS; DIABETES MELLITUS; DRUG USE; EARLY INTERVENTION; FEMALE; FUNGAL EYE INFECTION; FUNGAL SINUSITIS; GASTROINTESTINAL INFECTION; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INJURY; LUNG MYCOSIS; LYMPHOCYTOPENIA; MALE; MALNUTRITION; MONOCYTOPENIA; MORTALITY; MULTICENTER STUDY (TOPIC); NEUTROPENIA; NOSE INFECTION; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; SOLID TUMOR; SPAIN; SURGICAL TECHNIQUE; SURVIVAL; THERAPY DELAY; TREATMENT DURATION; ZYGOMYCOSIS;

ADULT; AGED; ANTIFUNGAL AGENTS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; COMBINED MODALITY THERAPY; DIABETES COMPLICATIONS; FEMALE; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKOPENIA; MALE; MIDDLE AGED; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SOFT TISSUE INFECTIONS; SPAIN; YOUNG ADULT; ZYGOMYCOSIS;

EID: 79954419076     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.09.008     Document Type: Article

References (21)

1. D.P. Kontoyiannis, and R.E. Lewis Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management Infect Dis Clin North Am. 20 2006 581 607 (Pubitemid 44375113)
2. M.M. Roden, T.E. Zaoutis, W.L. Buchanan, T.A. Knudsen, T.A. Sarkisova, and R.L. Schaufele Epidemiology and outcome of zygomycosis: a review of 929 reported cases Clin Infect Dis. 41 2005 634 653 (Pubitemid 41170352)
3. A. Glöckner, J.J. Vehreschild, and O.A. Cornely Zygomycosis - current epidemiological aspects Mycoses. 50 Suppl 1 2007 50 55 Erratum in: Mycoses. 2008;51:179 (Pubitemid 46495991)
4. D. Neofytos, D. Horn, E. Anaissie, W. Steinbach, A. Olyaei, and J. Fishman Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry Clin Infect Dis. 48 2009 265 273 Erratum in: Clin Infect Dis. 2009;48:690
5. S. Trifilio, S. Singhal, S. Williams, O. Frankfurt, L. Gordon, and A. Evens Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole Bone Marrow Transplant. 40 2007 451 456 (Pubitemid 47288224)
6. N. Singh, J.M. Aguado, H. Bonatti, G. Forrest, K.L. Gupta, and N. Safdar Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome J Infect Dis. 200 2009 1002 1011
7. L. Pagano, C.G. Valentini, M. Caira, and L. Fianchi ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies Br J Haematol. 146 2009 597 606
8. G.L. Petrikkos Lipid formulations of amphotericin B as first-line treatment of zygomycosis Clin Microbiol Infect. 15 Suppl 5 2009 Oct 87 92
9. M.D. Moen, K.A. Lyseng-Williamson, and L.J. Scott Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections Drugs. 69 2009 361 392
10. A.H. Groll, and T.J. Walsh Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections Mycoses. 49 Suppl 1 2006 7 16 (Pubitemid 44370096)
11. R.N. Greenberg, K. Mullane, J.A. van Burik, I. Raad, M.J. Abzug, and G. Anstead Posaconazole as salvage therapy for zygomycosis Antimicrob Agents Chemother. 50 2006 126 133 (Pubitemid 43042912)
12. J.A. van Burik, R.S. Hare, H.F. Solomon, M.L. Corrado, and D.P. Kontoyiannis Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases Clin Infect Dis. 42 2006 e61 e65 Erratum in: Clin Infect Dis. 2006;43:1376
13. C.R. Sims, and L. Ostrosky-Zeichner Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center Arch Med Res. 38 2007 90 93 (Pubitemid 44894615)
14. S. Ascioglu, J.H. Rex, B. de Pauw, J.E. Bennett, J. Bille, and F. Crokaert Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis. 34 2002 7 14 (Pubitemid 33152659)
15. L. Pagano, M. Offidani, L. Fianchi, A. Nosari, A. Candoni, and M. Piccardi Mucormycosis in hematologic patients Haematologica. 89 2004 207 214 (Pubitemid 38796496)
16. B. Gleissner, A. Schilling, I. Anagnostopolous, I. Siehl, and E. Thiel Improved outcome of zygomycosis in patients with hematological diseases? Leuk Lymphoma. 45 2004 1351 1360 (Pubitemid 38701909)
17. L. Pagano, C.G. Valentini, B. Posteraro, C. Girmenia, C. Ossi, and A. Pan Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) J Chemother. 21 2009 322 329
18. G. Chamilos, R.E. Lewis, and D.P. Kontoyiannis Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis Clin Infect Dis. 47 2008 503 509
19. M. Nucci, E.J. Anaissie, F. Queiroz-Telles, C.A. Martins, P. Trabasso, and C. Solza Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection Cancer. 98 2003 315 319 (Pubitemid 36828456)
20. M. Mikulska, A.M. Raiola, B. Bruno, E. Furfaro, M.T. Van Lint, and S. Bregante Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients Bone Marrow Transplant. 44 2009 361 370
21. G.N. Forrest, and K. Mankes Outcomes of invasive zygomycosis infections in renal transplant recipients Transpl Infect Dis. 9 2007 161 164 (Pubitemid 46669085)